
USD
$0.00
(0.00%
)At Close (As of Nov 5, 2025)
$11.18B
Market Cap
25.57
P/E Ratio
0.88
EPS
$22.96
52 Week High
$8.02
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.9B |
| Total Revenue | $4.4B |
| Cost Of Revenue | $2.5B |
| Costof Goods And Services Sold | $2.5B |
| Operating Income | $251M |
| Selling General And Administrative | $1.3B |
| Research And Development | $344M |
| Operating Expenses | $1.7B |
| Investment Income Net | - |
| Net Interest Income | -$235M |
| Interest Income | - |
| Interest Expense | $339M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $662M |
| Income Before Tax | $488M |
| Income Tax Expense | $150M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $338M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $827M |
| Ebitda | $1.5B |
| Net Income | $338M |
| Field | Value (USD) |
|---|---|
| Total Assets | $13B |
| Total Current Assets | $3.2B |
| Cash And Cash Equivalents At Carrying Value | $468M |
| Cash And Short Term Investments | $468M |
| Inventory | $1.6B |
| Current Net Receivables | $886M |
| Total Non Current Assets | $9.4B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $3.7B |
| Intangible Assets Excluding Goodwill | $3.7B |
| Goodwill | $4.4B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $287M |
| Other Non Current Assets | - |
| Total Liabilities | $6.5B |
| Total Current Liabilities | $1.3B |
| Current Accounts Payable | $296M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $44M |
| Total Non Current Liabilities | $5.2B |
| Capital Lease Obligations | - |
| Long Term Debt | $4.3B |
| Current Long Term Debt | $44M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $4.3B |
| Other Current Liabilities | $975M |
| Other Non Current Liabilities | $302M |
| Total Shareholder Equity | $6.1B |
| Treasury Stock | - |
| Retained Earnings | -$2B |
| Common Stock | - |
| Common Stock Shares Outstanding | $497M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $541M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $662M |
| Capital Expenditures | $147M |
| Change In Receivables | - |
| Change In Inventory | $44M |
| Profit Loss | - |
| Cashflow From Investment | $1.2B |
| Cashflow From Financing | -$1.5B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $338M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.9B |
| Total Revenue | $4.4B |
| Cost Of Revenue | $2.5B |
| Costof Goods And Services Sold | $2.5B |
| Operating Income | $251M |
| Selling General And Administrative | $1.3B |
| Research And Development | $344M |
| Operating Expenses | $1.7B |
| Investment Income Net | - |
| Net Interest Income | -$235M |
| Interest Income | - |
| Interest Expense | $339M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $662M |
| Income Before Tax | $488M |
| Income Tax Expense | $150M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $338M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $827M |
| Ebitda | $1.5B |
| Net Income | $338M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Elanco Animal Health Incorporated (ELAN) is a leading global provider of innovative animal health solutions, dedicated to improving the health and productivity of both companion animals and livestock. Based in Greenfield, Indiana, the company offers a comprehensive range of scientifically-backed products designed to address the unique challenges faced by veterinarians and producers. With a strong commitment to research and sustainable practices, Elanco is well-positioned to capitalize on the growing global demand for effective animal health solutions, ultimately supporting the welfare of animals while enhancing food supply chain efficiency. Through strategic investments and a focus on innovation, Elanco aims to drive robust growth in the animal health sector.